cobas® liat Bordetella panel
Delivering lab-quality results at the point of care
The cobas® liat Bordetella assay uses Nobel Prize-winning PCR technology to detect and differentiate B. pertussis, B. parapertussis, and B. holmesii from a single patient sample in just 15 minutes.
The cobas® liat Bordetella assay is authorized for use in CLIA waived settings, has no age restrictions, and requires less than one minute of hands-on time, providing quick, accurate results to support timely clinical decisions.
When symptoms of pertussis-like infections look the same, it is difficult to quickly identify the causative agent based on signs and symptoms alone. The cobas® liat Bordetella assay helps confidently diagnose and enables targeted treatment decisions when and where it’s needed the most.
cobas® liat Bordetella specifications
View full tablecobas® liat Bordetella specifications
Instrument |
cobas® liat system |
| Targets | B. pertussis, B. parapertussis, and B. holmesii |
| Registration | FDA 510(k) cleared, CLIA-waived |
Time to result |
~15 minutes |
Sample type |
Nasopharyngeal Swab |
Reagents |
Ready-to-use, pre-packed tube format |
Kit Storage |
2–8°C |
Collection media |
Universal Transport Media (UTM), 0.9% saline |
Technology |
Real-time PCR |
Sample extraction |
Fully automated and integrated |
Control |
Internal sample processing control, positive and negative controls |
cobas® liat Bordetella ordering information
View full tablecobas® liat Bordetella ordering information
| Material Number | Alternative Catalog Number |
Material Description |
Pack Size |
Pack size Description |
| 09857664190 | KIT COBAS LIAT Bordetella | 1 pack | 20 tests | |
| 09857672190 | COBAS LIAT Bordetella QC | 1 pack | 3 sets |
Use left and right arrow keys to scroll between the tabs
